Skip to content
Screener

Aurinia Pharmaceuticals AUPH Common Stock Shares Issued

Common Stock Shares Issued at other companies

Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
64.8M+29.4%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
60.9M+7.5%
ALN
Alnylam PharmaceuticalsALNY
133.7M+2.1%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
205.9M

Other financials

Income statement

See full
Revenue$83.2M+18.9%
Gross profit$76.7M+21.9%
Operating income$46.3M+131%
Net income$37.4M+73.9%
EPS (diluted)$0.28+75.0%

Balance sheet

See full
Cash & equivalents$179.8M+239%
Total debt$80.6M-17.7%
Total equity$614.9M+83.4%
Total assets$792.3M+57.6%

Cash flow

See full
Operating cash flow$52.6M+18.8%

Valuation

See full
Market cap$2.06B+36.6%
Enterprise value$1.96B+26.3%
P/E6.5×-18.3×
P/S6.6×+0.8×

Profitability

See full
Gross margin90.4%+0.8pp
Operating margin48.4%+28.4pp
Net margin100.8%+77.5pp

Returns & leverage

See full
Return on equity66.1%+48.8pp
Debt / equity0.1×-0.2×
Current ratio5.4×+0.2×

Where this comes from

Reported directly by Aurinia Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.

The source filing: Aurinia Pharmaceuticals’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 8:16 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001600620-26-000062
Line itemJune 30,2026December 31,2025
Total liabilities177,398170,256
Commitments and contingencies (Note 5)
Shareholders' equity
Common shares — no par value, Unlimited shares authorized, 132,907 and 132,323 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively1,117,2481,120,035
Additional paid-in capital76,192111,263
Accumulated other comprehensive loss(977)(599)
Accumulated deficit(577,599)(649,368)
Total shareholders' equity614,864581,331

Item 1. Financial Statements.

FAQ

What is Aurinia Pharmaceuticals's common stock shares issued?
Aurinia Pharmaceuticals (AUPH) reported common stock shares issued of 132.9M in Q2 2026.
How has Aurinia Pharmaceuticals's common stock shares issued changed year-over-year?
Aurinia Pharmaceuticals's common stock shares issued increased by 0.2% year-over-year, from 132.7M to 132.9M.
What is the long-term trend for Aurinia Pharmaceuticals's common stock shares issued?
Over 5 years (2020 to 2025), Aurinia Pharmaceuticals's common stock shares issued has grown at a 0.9% compound annual growth rate (CAGR), from 126.7M to 132.3M.
What does common stock shares issued mean?
The total number of shares that have been authorized and distributed by the corporation since its inception. This includes shares held by the public (outstanding) as well as any shares that the company has repurchased and holds in its treasury. It represents the historical volume of equity capital creation.

Ask your AI about Aurinia Pharmaceuticals's common stock shares issued.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude